266 related articles for article (PubMed ID: 24218174)
1. Centrally inserted external catheters and totally implantable ports for the delivery of chemotherapy: a systematic review and meta-analysis of device-related complications.
Kulkarni S; Wu O; Kasthuri R; Moss JG
Cardiovasc Intervent Radiol; 2014 Aug; 37(4):990-1008. PubMed ID: 24218174
[TBL] [Abstract][Full Text] [Related]
2. Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT.
Wu O; McCartney E; Heggie R; Germeni E; Paul J; Soulis E; Dillon S; Ryan C; Sim M; Dixon-Hughes J; Agarwal R; Bodenham A; Menne T; Jones B; Moss J
Health Technol Assess; 2021 Jul; 25(47):1-126. PubMed ID: 34318743
[TBL] [Abstract][Full Text] [Related]
3. A comparison of infections and complications in central venous catheters in adults with solid tumours.
Coady K; Ali M; Sidloff D; Kenningham RR; Ahmed S
J Vasc Access; 2015; 16(1):38-41. PubMed ID: 25198809
[TBL] [Abstract][Full Text] [Related]
4. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
[TBL] [Abstract][Full Text] [Related]
5. Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer.
Xu H; Chen R; Jiang C; You S; Zhu Q; Li Y; Li S; Zha X; Wang J
J Vasc Access; 2020 Sep; 21(5):609-614. PubMed ID: 31841061
[TBL] [Abstract][Full Text] [Related]
6. Totally implantable venous catheters for chemotherapy: experience in 500 patients.
Wolosker N; Yazbek G; Nishinari K; Malavolta LC; Munia MA; Langer M; Zerati AE
Sao Paulo Med J; 2004 Jul; 122(4):147-51. PubMed ID: 15543368
[TBL] [Abstract][Full Text] [Related]
7. Totally implantable ports connected to valved catheters for chemotherapy: experience from 350 Groshong devices.
Nishinari K; Wolosker N; Bernardi CV; Yazbek G
J Vasc Access; 2010; 11(1):17-22. PubMed ID: 20119917
[TBL] [Abstract][Full Text] [Related]
8. Infection of totally implantable venous access devices: A review of the literature.
Pinelli F; Cecero E; Degl'Innocenti D; Selmi V; Giua R; Villa G; Chelazzi C; Romagnoli S; Pittiruti M
J Vasc Access; 2018 May; 19(3):230-242. PubMed ID: 29512430
[TBL] [Abstract][Full Text] [Related]
9. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
[TBL] [Abstract][Full Text] [Related]
10. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
[TBL] [Abstract][Full Text] [Related]
11. Retained catheter: a rare complication associated with totally implantable venous ports.
Nishinari K; Bernardi CV; Wolosker N; Yazbek G
J Vasc Access; 2010; 11(2):159-61. PubMed ID: 20119912
[TBL] [Abstract][Full Text] [Related]
12. Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients: A systematic review and meta-analysis.
Jiang M; Li CL; Pan CQ; Cui XW; Dietrich CF
J Thromb Haemost; 2020 Sep; 18(9):2253-2273. PubMed ID: 32479699
[TBL] [Abstract][Full Text] [Related]
13. Effect of catheter diameter on left innominate vein in breast cancer patients after totally implantable venous access port placement.
Song MG; Seo TS; Kim YH; Cho SB; Chung HH; Lee SH; Jung E
J Vasc Access; 2018 Nov; 19(6):615-619. PubMed ID: 29560786
[TBL] [Abstract][Full Text] [Related]
14. Fractures of totally implantable central venous ports: more than fortuity. A three-year single center experience.
Balsorano P; Galducci G; De Fanti I; Evans SK; De Gaudio AR; Pelagatti C
J Vasc Access; 2014; 15(5):391-5. PubMed ID: 25041921
[TBL] [Abstract][Full Text] [Related]
15. Peripherally inserted central catheters in the treatment of children with cancer: Results of a multicenter study.
Rykov MY; Zaborovskij SV; Shvecov AN; Shukin VV
J Vasc Access; 2018 Jul; 19(4):378-381. PubMed ID: 29546772
[TBL] [Abstract][Full Text] [Related]
16. Totally implantable central venous access ports. Analysis of 700 cases.
Barbetakis N; Asteriou C; Kleontas A; Tsilikas C
J Surg Oncol; 2011 Nov; 104(6):654-6. PubMed ID: 21671465
[TBL] [Abstract][Full Text] [Related]
17. Common and uncommon complications of totally implantable central venous ports: a pictorial essay.
Perdikakis E; Kehagias E; Tsetis D
J Vasc Access; 2012; 13(3):345-50. PubMed ID: 22307469
[TBL] [Abstract][Full Text] [Related]
18. Infectious morbidity associated with long-term use of venous access devices in patients with cancer.
Groeger JS; Lucas AB; Thaler HT; Friedlander-Klar H; Brown AE; Kiehn TE; Armstrong D
Ann Intern Med; 1993 Dec; 119(12):1168-74. PubMed ID: 8239247
[TBL] [Abstract][Full Text] [Related]
19. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.
Ross MN; Haase GM; Poole MA; Burrington JD; Odom LF
Surg Gynecol Obstet; 1988 Aug; 167(2):141-4. PubMed ID: 3400032
[TBL] [Abstract][Full Text] [Related]
20. Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis.
Heibl C; Trommet V; Burgstaller S; Mayrbaeurl B; Baldinger C; Koplmüller R; Kühr T; Wimmer L; Thaler J
Eur J Cancer Care (Engl); 2010 Sep; 19(5):676-81. PubMed ID: 19708941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
